Investigation of Danazol as a contraceptive agent.
D001831:Body Temperature; D003271:Contraceptive Agents, Female; D003338:Corpus Luteum / Q000187:drug effects*; D003613:Danazol / Q000494:pharmacology*; D004341:Drug Evaluation; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D008183:Luteal Phase / Q000187:drug effects*; D007986:Luteinizing Hormone / Q000097:blood; D008598:Menstruation / Q000187:drug effects*; D011245:Pregnadienes / Q000494:pharmacology*; D011374:Progesterone / Q000097:blood
D003271:Contraceptive Agents, Female; D011245:Pregnadienes; D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D003613:Danazol